Skip to search formSkip to main contentSkip to account menu

HER2 Positive Breast Carcinoma

Known as: HER2 Overexpressing Subtype of Breast Carcinoma, HER2 Overexpressing Breast Carcinoma, HER2 Positive Breast Cancer 
A biologic subset of breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BackgroundLapatinib is a commonly used drug that interrupts signaling from the epidermal growth factor receptors, EGFR and HER2… 
2015
2015
MicroRNAs (miRNAs) are short, 20‑24 nucleotide non‑coding RNAs, which are involved in multiple biological processes, including… 
2014
2014
The aryl hydrocarbon receptor (AhR), a client protein of heat shock protein 90 (Hsp90), is a ligand-activated transcription… 
2013
2013
PURPOSE Mutations that activate the PIK3CA oncogene and inhibit the tumor suppressor gene PTEN action are commonly found in… 
Review
2010
Review
2010
Exploration of anabolic pathways in osteoblasts revealed that Zfp521, a 30‐zinc finger protein, is highly expressed at the… 
Review
2009
Review
2009
INTRODUCTION The opiorphins are a newly characterized class of peptides that act as potent endogenous neutral endopeptidase (NEP… 
2004
2004
573 Purpose: This randomized multicenter phase III trial evaluated the efficacy and safety of trastuzumab with paclitaxel 175 mg…